Výsledky vyhledávání - "E. M. Terveer"

Akademický článek

Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial

Autor: J. S. W. Borgers, F. H. Burgers, E. M. Terveer, M. E. van Leerdam, C. M. Korse, R. Kessels, C. C. Flohil, C. U. Blank, T. N. Schumacher, M. van Dijk, J. G. E. Henderickx, J. J. Keller, H. W. Verspaget, E. J. Kuijper, J. B. A. G. Haanen

Publikováno v: BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)

Abstract Background The gut microbiome plays an important role in immune modulation. Specifically, presence or absence of certain gut bacterial taxa has been associated with better antitumor immune responses. Furthermore, in trials using fecal microb

Externí odkaz: https://doaj.org/article/6bd20975d8584eeab94f604ed9b0c810

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection from a Randomized Controlled Trial and Review of the Literature

Autor: R. E. Ooijevaar, E. van Nood, A. Goorhuis, E. M. Terveer, J. van Prehn, H. W. Verspaget, Y. H. van Beurden, M. G. W. Dijkgraaf, J. J. Keller

Publikováno v: Microorganisms, Vol 9, Iss 3, p 548 (2021)

Fecal microbiota transplantation (FMT) has become a well-established treatment for recurrent Clostridioides difficile infection (rCDI). While short-term outcomes and adverse events relating to FMT have been well documented, there still is a paucity o

Externí odkaz: https://doaj.org/article/4f6c99738201456da614143db6c60e92

Zobrazit plný text záznamu

Akademický článek

Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent infection in patients with inflammatory bowel disease

Autor: Emilie (E.) van Lingen, Simon (S. M. D.) Baunwall, Simone (S. C.) Lieberknecht, Nicolas (N.) Benech, Gianluca (G.) Ianiro, Harry (H.) Sokol, Alessandro (A.) Gasbarrini, Giovanni (G.) Cammarota, Marcel (M. K.) Eriksen, Andrea (A. E.) van der Meulen-de Jong, Elizabeth (E. M.) Terveer, Hein (H. W.) Verspaget, Maria (M.) Vehreschild, Christian (C. L.) Hvas, Josbert (J. J.) Keller

Publikováno v: Therapeutic Advances in Gastroenterology, Vol 16 (2023)

Background: Patients with inflammatory bowel disease (IBD) are at an increased risk of developing Clostridioides difficile infection (CDI). Treatment of CDI in patients with IBD is challenging due to higher failure rates and concomitant IBD activity.

Externí odkaz: https://doaj.org/article/d1e5885c4fe14d608dda3e4027daaf28

Zobrazit plný text záznamu

Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease

Publikováno v: van Lingen, E, Baunwall, S, Lieberknecht, S, Benech, N, Ianiro, G, Sokol, H, Gasbarrini, A, Cammarota, G, Eriksen, M, van der Meulen-de Jong, A, Terveer, E, Verspaget, H, Vehreschild, M, Hvas, C & Keller, J 2023, ' Short-and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease ', Therapeutic Advances in Gastroenterology, vol. 16 . https://doi.org/10.1177/17562848231156285

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ae34fbbe36826e125dd2de3ffee8d38
https://doi.org/10.1177/17562848231156285

Zobrazit plný text záznamu

P328 Faecal microbiota transplantation as treatment for recurrent Clostridiodes difficile infection in patients with inflammatory bowel disease: Experiences of the Netherlands donor faeces bank

Autor: Ed J. Kuijper, E Van Lingen, E M Terveer, A. E. van der Meulen-de Jong, Josbert J. Keller, K E W Vendrik

Publikováno v: Journal of Crohn's and Colitis. 14:S317-S318

Background In recent years Faecal Microbiota Transplantation (FMT) is effectively implemented as an approved treatment approach of refractory Clostridiodes difficile infection (rCDI). In patients with inflammatory bowel disease (IBD) the prevalence o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2b98d3b4d8072669e82a13d25e874f25
https://doi.org/10.1093/ecco-jcc/jjz203.457

Zobrazit plný text záznamu

[Faecal microbiota transplantation: indications in perspective]

Autor: Y H, van Beurden, E M, Terveer, J J, Keller, E J, Kuijper, C J J, Mulder, C M J E, Vandenbroucke-Grauls

Publikováno v: Nederlands tijdschrift voor geneeskunde. 161

As yet, with cure rates around 85%, recurrent Clostridium difficile infection is the only definite indication for faecal microbiota transplantation.- Faecal microbiota transplantation induces clinical remission and endoscopic improvements in 24-30% o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b51747628fe51a19a402032e83e06068
https://pubmed.ncbi.nlm.nih.gov/29076444

Zobrazit plný text záznamu

The tortuous history of the implementation of early ambulation after delivery

Autor: Catharina Jacoba Maria Doggen, K.J. van Stralen, F.M. Helmerhorst, E M Terveer, Jan P. Vandenbroucke

Publikováno v: Journal of the Royal Society of Medicine, 100(2), 90-96. SAGE Publications

One of earliest known risk factors for venous thrombosis is pregnancy. As long ago as 1718 Mauriceau described the ‘milk leg’. He suspected that, in pregnant women, a venous thrombosis in the leg was caused by ‘redundancy and metastasis’ of b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::106b8bb2ccb5fbc255dff5a692b862a7
https://doi.org/10.1258/jrsm.100.2.90

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání